指南与共识鼻科睡眠呼吸障碍

临床实践指南:鼻整形术后改善鼻部形态与功能的执行摘要

Clinical Practice Guideline: Improving Nasal Form and Function after Rhinoplasty Executive Summary.
指南 / 共识 · Otolaryngol Head Neck Surg · 2017-01-01

本指南针对≥15岁鼻整形患者,围绕术前评估、患者教育、围手术期用药与鼻腔填塞等提出循证推荐,旨在优化患者安全与手术效果,减少不必要变异。

要点

  • 术前应询问患者手术动机与期望,评估睡眠呼吸暂停、躯体变形障碍等合并症。
  • 应向患者说明术后预期、鼻腔呼吸影响、并发症及可能需再次鼻部手术。
  • 术后抗生素使用不超过24小时,不常规鼻腔填塞,可考虑围手术期全身激素。

核心结论

  • 指南旨在利用当前循证医学实践与数据,就围手术期及术后策略达成共识,以最大化患者安全并优化手术结果。

研究设计与样本

  • 指南制定小组针对鼻整形患者管理提出循证推荐,目标人群为所有年龄≥15岁的患者。

主要发现

  • 2014年美国报告鼻整形手术超过200000例,平均手术费用通常超过4000美元。

关键数值与推荐

  • 推荐临床医生询问所有寻求鼻整形患者的动机与期望,反馈期望是否现实并记录于病历。
  • 推荐评估可能改变或禁忌手术的合并症,包括阻塞性睡眠呼吸暂停、躯体变形障碍、出血性疾病或长期使用局部血管收缩性鼻内药物。
  • 推荐外科医生或其指定人员在术前评估中评价鼻气道阻塞。
  • 推荐教育患者术后预期、手术对鼻呼吸能力的影响、潜在并发症及未来可能需要鼻部手术。
  • 推荐对确诊阻塞性睡眠呼吸暂停的患者咨询手术对鼻气道阻塞的影响及该病对围手术期管理的影响。

临床怎么用

  • 临床医生应将上述推荐用于鼻整形候选者的术前评估、教育、围手术期用药及术后随访。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective Rhinoplasty, a surgical procedure that alters the shape or appearance of the nose while preserving or enhancing the nasal airway, ranks among the most commonly performed cosmetic procedures in the United States, with >200,000 procedures reported in 2014. While it is difficult to calculate the exact economic burden incurred by rhinoplasty patients following surgery with or without complications, the average rhinoplasty procedure typically exceeds $4000. The costs incurred due to complications, infections, or revision surgery may include the cost of long-term antibiotics, hospitalization, or lost revenue from hours/days of missed work. The resultant psychological impact of rhinoplasty can also be significant. Furthermore, the health care burden from psychological pressures of nasal deformities/aesthetic shortcomings, surgical infections, surgical pain, side effects from antibiotics, and nasal packing materials must also be considered for these patients. Prior to this guideline, limited literature existed on standard care considerations for pre- and postsurgical management and for standard surgical practice to ensure optimal outcomes for patients undergoing rhinoplasty. The impetus for this guideline is to utilize current evidence-based medicine practices and data to build unanimity regarding the peri- and postoperative strategies to maximize patient safety and to optimize surgical results for patients. Purpose The primary purpose of this guideline executive summary is to provide evidence-based recommendations for clinicians who either perform rhinoplasty or are involved in the care of a rhinoplasty candidate, as well as to optimize patient care, promote effective diagnosis and therapy, and reduce harmful or unnecessary variations in care. The target audience is any clinician or individual, in any setting, involved in the management of these patients. The target patient population is all patients aged ≥15 years. The guideline is intended to focus on knowledge gaps, practice variations, and clinical concerns associated with this surgical procedure; it is not intended to be a comprehensive reference for improving nasal form and function after rhinoplasty. Recommendations in this guideline concerning education and counseling to the patient are intended to include the caregiver if the patient is <18 years of age. Action Statements The Guideline Development Group made the following recommendations: (1) Clinicians should ask all patients seeking rhinoplasty about their motivations for surgery and their expectations for outcomes, should provide feedback on whether those expectations are a realistic goal of surgery, and should document this discussion in the medical record. (2) Clinicians should assess rhinoplasty candidates for comorbid conditions that could modify or contraindicate surgery, including obstructive sleep apnea, body dysmorphic disorder, bleeding disorders, or chronic use of topical vasoconstrictive intranasal drugs. (3) The surgeon, or the surgeon's designee, should evaluate the rhinoplasty candidate for nasal airway obstruction during the preoperative assessment. (4) The surgeon, or the surgeon's designee, should educate rhinoplasty candidates regarding what to expect after surgery, how surgery might affect the ability to breathe through the nose, potential complications of surgery, and the possible need for future nasal surgery. (5) The clinician, or the clinician's designee, should counsel rhinoplasty candidates with documented obstructive sleep apnea about the impact of surgery on nasal airway obstruction and how obstructive sleep apnea might affect perioperative management. (6) The surgeon, or the surgeon's designee, should educate rhinoplasty patients before surgery about strategies to manage discomfort after surgery. (7) Clinicians should document patient satisfaction with their nasal appearance and with their nasal function at a minimum of 12 months after rhinoplasty. The guideline development group made recommendations against certain actions: (1) When a surgeon, or the surgeon's designee, chooses to administer perioperative antibiotics for rhinoplasty, he or she should not routinely prescribe antibiotic therapy for a duration >24 hours after surgery. (2) Surgeons should not routinely place packing in the nasal cavity of rhinoplasty patients (with or without septoplasty) at the conclusion of surgery. The panel group made the following statement an option: (1) The surgeon, or the surgeon's designee, may administer perioperative systemic steroids to the rhinoplasty patient.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Ishii LE, Tollefson TT, Basura GJ, et al. Clinical Practice Guideline: Improving Nasal Form and Function after Rhinoplasty Executive Summary. Otolaryngol Head Neck Surg. 2017. PMID: 28145848. doi:10.1177/0194599816683156

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。